September 2021 - BioMedWire (BMW)

ThursdaySep 30, 2021 1:24 pm

Seven Symptoms of Brain Cancer You Shouldn’t Ignore

An individual’s lifetime risk of developing a spinal cord or malignant brain tumor is under 1%. The American Cancer Society reveals that even when primary brain tumors do occur, more than half of them are benign, which means that they are not cancerous. Dr. Alyx B. Porter, a neuro-oncologist who is also the medical director of the Mayo Clinic Outpatient Practice in Arizona, states that the main known risk factors for brain tumors are a family history with genetic predisposition to some cancers or tumors and being exposed to radiation. Below are the most common symptoms of a brain tumor,…

ThursdaySep 30, 2021 11:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Achieves Most Important Milestone Yet with Submission of IND Application for Phase 2a Clinical Trial

Tryp Therapeutics on September 22 submitted an IND application to the FDA to evaluate its oral formulation of synthetic psilocybin, TRP-8802, in a Phase 2a clinical study The study seeks to evaluate TRP-8802 for the treatment of patients with eating disorders and will enroll 10 patients According to Tryp Chairman and CEO, the submission is the first of several IND filings the company intends to make in the coming months Tryp is also preparing for Phase 2b clinical trials, which will evaluate its proprietary drug candidate, TRP-8803 During a recent investor presentation, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical…

WednesdaySep 29, 2021 10:53 am

Treatment Modalities for Soft Tissue Sarcomas in the Extremities Differ by Age Group

A new study has found that young individuals suffering from extremity soft tissue sarcoma are less likely to receive radiation and more likely to undergo chemotherapy when compared with older individuals. The study was reported in “JAMA Network Open.” Extremity soft tissues sarcomas are a rare group of tumors that commonly occur in an individual’s extremities. For their research, the scientists carried out a retrospective study that included more than 8,900 patients and compared the utilization of definitive treatment from 2004 to 2014. The cohorts from the National Cancer Database comprised of about 3,750 patients aged 65 and above, roughly…

TuesdaySep 28, 2021 12:31 pm

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) 10 Years in the Making: Innovation Leads to Multi (Pan)-Cancer Screening

After ten years, the concept of (multi)pan-cancer screening pioneered by AnPac Bio-Medical Science Co., Ltd. (AnPac Bio) has finally been accepted and the industry is shifting toward early screening technology that detects multiple cancers in blood at one time. In 2010, AnPac Bio proposed the theory of multi-cancer screening. At the time, the industry was divided over this innovative approach. The Company, however, persevered with the multi-cancer detection concept in an effort which included multiple patent applications and the launch of full technology and product development to help drive a generational shift in the face of a scientific community that…

TuesdaySep 28, 2021 11:19 am

RYAH Group Inc. (CSE: RYAH) Provides Insight into Cannabis Medical Space in Brazil

Medical cannabis reform in Brazil is slowly taking shape Challenges include the cost of medical cannabis products and medical cannabis patients living close to available access With its background in connected devices, big data, and technology, RYAH appears well qualified to provide insight on medical cannabis around the world While the cannabis world’s attention is often focused on what’s happening in North America, activity in Latin America may be making significant progress. For example, a recent blog post (https://ibn.fm/t36SM) from RYAH Group (CSE: RYAH) states that “Brazil, one of the region’s largest markets, is quietly, if incrementally, making advances toward…

TuesdaySep 28, 2021 9:30 am

Study Discovers Link Between Gut Bacteria, Mental Health Conditions

A new study conducted by researchers at the Institute of Psychiatry, Psychology and Neuroscience has discovered an overlapping environment in the gut microbiota of individuals living with mental health conditions such as anxiety, bipolar disorder and depression. Bipolar disorder is a disorder that has been linked to extreme mood swings, which range from manic and emotional highs to depressive lows. On the other hand, gut bacteria is a community of microorganisms that dwell in the human gastrointestinal tract. This includes other microorganism types, as well as viruses, bacteria and fungi. Prior research has highlighted the important role gut bacteria plays…

MondaySep 27, 2021 1:26 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Reveals Attendance at This Year’s H.C. Wainwright Global Investment Conference

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently revealed its participation at the annual H.C. Wainwright Global Investment Conference, held between September 13-15, 2021 Through its sugarBEAT flagship product, Nemaura has sought to capitalize on the expanding Type 2 Diabetes market, expected to reach an annual value of $59 billion by 2025 Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs; the company’s flagship product, the sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor designed…

MondaySep 27, 2021 12:14 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Mental Health Treatment Innovation

WHO survey reports that mental health services in 93% of countries around the world have been disrupted or halted as a result of COVID-19 People with pre-existing mental, neurological or substance-use disorders are more vulnerable to SARS-CoV-2 infection Cybin is on a mission to revolutionize mental healthcare A World Health Organization (“WHO”) survey covering 130 countries is calling attention to the fact that today’s demand for mental health, which has been rocked by the COVID-19 pandemic, is only increasing (https://ibn.fm/hzmXq). Cybin (NEO: CYBN) (NYSE American: CYBN) is focused on meeting that need and is committed to finding even more effective…

MondaySep 27, 2021 10:35 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leading the Way in Early Cancer Detection Space

Up to 50% of cancer is preventable, while other types can be detected or treated early, often resulting in complete remission for patients AnPac Bio-Medical Science Co., Ltd. uses blood-based testing to detect many types of cancer (multi-cancer tests) and pre-cancer diseases, predicting its potential to occur in the future Company’s proprietary CDA technology is powered by a database of over 220,000 clinical and general population test samples and cases and leverages a proprietary algorithm to generate personalized cancer screening Its follow-up study on multi-cancer risk assessment tests is believed to be the largest on-going study which has demonstrated its…

MondaySep 27, 2021 9:30 am

How Data Analytics Can Be Used in the Healthcare Sector

Healthcare usually demands the ability to collect and analyze data from patients, which then allows physicians to make a choice on the individual’s mode of treatment, needed medications and so on. Medical practitioners can use data analytics to enhance decision making. This refers to the process of interpreting quantitative data to identify trends and answer questions. Data can be analyzed using algorithms and software or manually, with the visual representation of data through charts and graphs also being useful in demonstrating trends and designing presentations. The main types of data analysis include prescriptive analysis, predictive analysis, diagnostic analysis and descriptive…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

Month: September 2021

Seven Symptoms of Brain Cancer You Shouldn’t Ignore

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Achieves Most Important Milestone Yet with Submission of IND Application for Phase 2a Clinical Trial

Treatment Modalities for Soft Tissue Sarcomas in the Extremities Differ by Age Group

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) 10 Years in the Making: Innovation Leads to Multi (Pan)-Cancer Screening

RYAH Group Inc. (CSE: RYAH) Provides Insight into Cannabis Medical Space in Brazil

Study Discovers Link Between Gut Bacteria, Mental Health Conditions

Nemaura Medical Inc. (NASDAQ: NMRD) Reveals Attendance at This Year’s H.C. Wainwright Global Investment Conference

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Mental Health Treatment Innovation

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leading the Way in Early Cancer Detection Space

How Data Analytics Can Be Used in the Healthcare Sector

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search